Brief Report: Anti–Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis

Arthritis and Rheumatology

Volumn 68, Issue 11, 2016, Pages 2778-2783

  Betteridge, Zoe E ^a   Woodhead, Felix ^b   Lu, Hui ^a   Shaddick, Gavin ^a   Bunn, Christopher C ^c   Denton, Christopher P ^d   Abraham, David J ^e   du Bois, Roland M ^f   Lewis, Mervyn ^g   Wells, Athol U ^h   McHugh, Neil J ^a  

^a UNIVERSITY OF BATH   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^h ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; DNA DIRECTED RNA POLYMERASE III; DNA TOPOISOMERASE;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MIDDLE AGED; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; SYSTEMIC SCLEROSIS; COMPLICATION; COUNTER IMMUNOELECTROPHORESIS; IMMUNOLOGY; INDIRECT FLUORESCENT ANTIBODY TECHNIQUE; LUNG DISEASES, INTERSTITIAL; WESTERN BLOTTING;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; COUNTERIMMUNOELECTROPHORESIS; DNA TOPOISOMERASES, TYPE I; EUKARYOTIC INITIATION FACTOR-2B; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOPRECIPITATION; LUNG DISEASES, INTERSTITIAL; MALE; MASS SPECTROMETRY; MIDDLE AGED; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC;

EID: 84992536249     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39755     Document Type: Article

References (13)

1. Tan FK. Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin North Am 2003;29:211–37.
2. Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis. Autoimmun Rev 2013;12:340–54.
3. Steen VD. The many faces of scleroderma. Rheum Dis Clin North Am 2008;34:1–15; v.
4. Domsic RT. Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement. Curr Opin Rheumatol 2014;26:646–52.
5. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
6. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202–5.
7. Bernstein RM, Bunn CC, Hughes GR. Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 1982;41:554–5.
8. Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA Jr. A comparison between anti-Th/To– and anticentromere antibody–positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003;48:203–9.
9. Pavitt GD. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans 2005;33:1487–92.
10. Betteridge Z, Chinoy H, Vencovsky J, Cooper R, McHugh N. Identification of autoantibodies to a novel autoantigen protein complex (EIF3) in polymyositis patients. Rheumatology (Oxford) 2011;50 Suppl 3:167.
11. Satoh M, Chan JY, Ceribelli A, Vazquez del-Mercado M, Chan EK. Autoantibodies to Argonaute 2 (Su antigen). Adv Exp Med Biol 2013;768:45–59.
12. Carter CJ. Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage. Immunopharmacol Immunotoxicol 2012;34:21–35.
13. Fattal I, Shental N, Molad Y, Gabrielli A, Pokroy-Shapira E, Oren S, et al. Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA. Immunology 2014;141:276–85.